Schedule 13G ownership disclosure
BRIDGEBIO PHARMA INC
Common Stock · CUSIP: 10806X102
Event date: 2025-12-31
- Filing-level shares
- 11,000,457
- Percent of class
- 5.7%
- JANUS HENDERSON GROUP PLC
Shares: 11,000,457 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-26-000074
- Form type
- SCHEDULE 13G
- Filer
- BridgeBio Pharma, Inc.
- CIK
- CIK 1743881
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership